API
< Back to all clusters
[HEALTH] · Canada, United States, Spain, France, Israel · 5 sources

started · updated

Covid-19 PJ.2.1 variant spreads globally with reported sore throat symptoms

The PJ.2.1 Covid-19 variant, a descendant of the SARS-CoV-2 lineage, is spreading across multiple countries including Canada, the United States, Spain, France, Israel, Singapore, Australia, and New Zealand. First documented in Ontario, Canada, in May 2026, the variant is characterized by multiple genetic changes in its spike protein rather than gradual mutations.

Laboratory findings suggest the variant may bind more effectively to the ACE2 receptor, potentially increasing its ability to enter human cells. However, health experts and the World Health Organization (WHO) note there is currently no convincing evidence that PJ.2.1 causes more severe illness, higher hospitalization rates, or increased mortality compared to previous variants.

Medical specialists, including virologist Elena Malinnikova and epidemiologist Gennady Onishchenko, have identified severe sore throat and prolonged fatigue as prominent symptoms. Other possible symptoms include fever, cough, runny nose, headache, and muscle aches. While the variant is being closely monitored by the WHO, experts currently agree it is unlikely to trigger a new pandemic.

Entities

Canada · Elena Malinnikova · Gennady Onishchenko · Journal of Infection · SARS-CoV-2 · World Health Organization

Claims

What the coverage asserts, and how many sources carry each claim.